MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202541002589 A) filed by Manipal Academy Of Higher Education on January 11, 2025, for A Method And Composition For Targeted Inhalable Nanoparticles To Treat Lung Cancer.
Inventors include Usha Y Nayak; Akanksha D Dessai; and Sanjay Garg.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present invention relates to an inhalable hybrid lipid-polymer nanoparticle (HLPN) formulation designed for the co-delivery of Nintedanib and Docetaxel to treat Non-Small Cell Lung Cancer (NSCLC). The invention overcomes the shortcomings of traditional therapies, including systemic toxicity, inadequate drug localiza...